General characteristics and mechanism of action
The group of selective inhibitors of neuronal serotonin reuptake acts directly on brain neurons. The main biochemical process consists in the inhibition of serotonin reuptake, which leads to a predictable increase in serotonergic activity in the body.
Unlike non-selective agents such as tricyclic antidepressants (TCAs), these drugs have a fundamentally different receptor profile:
- They possess minimal or entirely absent M-cholinolytic activity.
- They exert only a negligible effect on alpha-adrenoreceptors and histamine receptors.
The main clinical advantage of such a profile is a substantially lower frequency of side effects that typically arise from unwanted blockade of peripheral receptors.
Pharmacodynamics and features of Paroxetine
A prominent representative of the group is Paroxetine. Its pharmacodynamic action is based on the preferential blockade of neuronal serotonin reuptake. Notably, among all known drugs in this group, it is considered the most potent inhibitor.
Clinical effects develop gradually provided regular intake is maintained:
- The antidepressant effect manifests after a latency period that averages 10 to 14 days.
- The spectrum of action includes a pronounced reduction in anxiety, alleviation of depressive manifestations, and overall correction of sleep disorders.
- The primary clinical indication is major depressive disorder.
By analogy with the general group, paroxetine compares favorably to tricyclic antidepressants with a less pronounced M-cholinolytic effect and weak antihistaminic activity.
Pharmacokinetics and distribution
Drug compounds of this group are distinguished by specific pharmacokinetic properties. The drugs are characterized by a large volume of distribution: they actively accumulate in body tissues, whereas only about 1% of the administered dose circulates in blood plasma.
Paroxetine is characterized by the following parameters:
- Absorption: completely absorbed from the gastrointestinal tract.
- Metabolism: undergoes an intensive first-pass metabolism process in the liver, which reduces overall bioavailability. Food intake does not affect the degree of absorption.
- Regimen: prescribed to patients standardly once daily.
- Concentration: peak plasma concentration is reached after 2–8 hours, while a steady-state concentration is established after 7–14 days of regular intake.
Safety profile and drug interactions
Despite good tolerability, SSRIs have a certain spectrum of adverse reactions. Frequent side effects include dyspeptic disorders such as nausea, headaches (cephalgia), and skin pruritus. Autonomic disturbances are less common: mydriasis, accommodation disorders, tachycardia, arrhythmias, and orthostatic hypotension.
Features of other representatives:
- Fluvoxamine is completely devoid of sedative action and does not affect peripheral cholinergic and adrenergic receptors.
- Sertraline successfully combines antidepressant properties with a mild sedative effect, while also not affecting peripheral innervation.
Crucial risk: the combination of SSRIs with non-selective monoamine oxidase inhibitors (MAOIs) is an absolute contraindication. Excessive accumulation of serotonin in the synaptic cleft causes serotonin syndrome with a dangerous clinical presentation: ranging from confusion and psychomotor agitation to muscle rigidity, hyperthermia, and cardiovascular collapse. Prevention requires a mandatory interval ("washout period") of at least two weeks.
Briefly: answers to topical questions
Which drugs are included in the group of selective serotonin reuptake inhibitors?
The group of selective serotonin reuptake inhibitors includes the following drugs, whose mechanism of action is related to the preferential blockade of neuronal serotonin reuptake:
- Paroxetine (Paroxetine) — considered the strongest inhibitor in the group;
- Fluvoxamine — devoid of sedative effect;
- Sertraline (Sertraline) — combines antidepressant effect with a sedative one;
- Fluoxetine (Fluoxetine) — possesses psychostimulating effect;
- Citalopram (Citalopram);
- Escitalopram (Escitalopram).
What are the main indications for the use of SSRIs?
The main areas of application for SSRIs confirmed by sources:
- Depressive states: major depressive disorders, classical depressive states.
- Neuroses: especially obsessive-compulsive disorder and panic attacks; serotonergic agents, including SSRIs, are more frequently used to prevent recurring panic attacks.
- Anxiety disorders after ischemic stroke: SSRIs are recommended to reduce anxiety symptoms.
- Climacteric syndrome: relief of vasomotor and psychoemotional symptoms, sleep improvement; in Russia, this use is indicated as off-label.
- Behavioral correction in dysthymic and anxious-suspicious personalities.
- Somatic and psychosomatic diseases.
- Affective disorders in multiple system atrophy: depression and anxiety; SSRIs, such as paroxetine, are indicated as drugs of choice.
With which drugs, in addition to MAO inhibitors, is it dangerous to combine SSRIs due to the risk of serotonin syndrome?
In addition to combinations with MAO inhibitors, sources indicate a link between serotonin syndrome and:
- MAOI-B inhibitors in patients with Parkinson's disease when combined with SSRI antidepressants;
- tramadol, for which a specific risk of developing serotonin syndrome is described due to excessive serotonergic activity in the CNS.
A direct ban on the combination of SSRIs with tramadol is not formulated in the sources, but the risk of serotonin syndrome for tramadol is indicated.
What are the contraindications for prescribing SSRIs, other than concurrent use of MAO inhibitors?
Apart from concurrent intake of MAO inhibitors, sources indicate the following limitations for specific SSRIs:
- Pregnancy: in the absence of serious indications, psychopharmacotherapy is not prescribed to pregnant women; SSRIs are named among the drugs of choice when treatment is unavoidable, but strictly except for paroxetine.
- Tamoxifen intake in female breast cancer patients: paroxetine, fluoxetine, and sertraline should be avoided since they affect tamoxifen metabolism and reduce its efficacy.
Paroxetine — "potent syrup": the strongest serotonin inhibitor, but it must be taken once daily, and combining it with MAOs is strictly prohibited (remember the two-week "washout"!).
Class and exam questions
Why are SSRIs better tolerated than tricyclic antidepressants?
Due to selectivity, they have minimal or absent M-cholinolytic action and also barely affect alpha-adrenoreceptors and histamine receptors, which spares patients from numerous side effects.
When does the antidepressant effect occur with paroxetine intake?
The antidepressant effect develops gradually with regular intake, having a latency period averaging 10 to 14 days.
What are the main manifestations of serotonin syndrome in overdose or dangerous combinations?
The syndrome manifests as mental disorders (confusion, psychomotor agitation), as well as somatic and neurological disorders (muscle rigidity, hyperthermia, collapse).
Why is a washout period necessary when switching from MAO inhibitors to SSRIs?
An interval of at least 2 weeks is necessary to prevent a critical increase in synaptic serotonin concentration and the development of severe serotonin syndrome.
What else to study on this topic
- Comparative receptor profile of SSRIs and tricyclic antidepressants
- Pharmacokinetic features of paroxetine metabolism during first-pass hepatic metabolism
- Differences in the pharmacological effects of fluvoxamine and sertraline
- Pathogenesis and clinical presentation of serotonin syndrome
- Rules and duration of the washout period when switching antidepressant therapy
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Selective Serotonin Reuptake Inhibitors" and 5,304 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.